For all inquiries regarding Tissue Microarrays with survival data, please contact us at support@taibsbio.cn
首页 > 组织芯片 > > RLN1261a
tissue microarray-RLN1261a
  • 点数:
    126
    例数:
    63
    点样直径(mm):
    1
    厚度(µm):
    5
    行数:
    11
    列数:
    12
    组织阵列类型:
    FFPE
    种属:
    Human
RLN1261a
加入收藏

描述: Lung cancer tissue array, including pathology grade, TNM and clinical stage, 63 cases/126 cores, replacing RLN1261

详情: Lung carcinoma tissue microarray, containing 34 cases adenocarcinoma, 2 adenosquamous carcinoma, 25 squamous cell carcinoma, plus 2 adjacent normal lung tissue, duplicate core per case

应用程序: Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page

备注

1. TMA slides were sectioned and stored at 4°C and may not be fresh cut, but still suitable for IHC. Please request fresh cut if experiment involves phospho-specific antibodies, RNA studies, FISH or ISH, etc. A minimum of 3 slides per TMA must be purchased to cover the cost of trimming for fresh sectioning.
2. Most TMA slides were not coated with an extra layer of paraffin (tissue cores can be easily seen on the glass). To prevent tissue detachment during antigen retrieval, unbaked slides must be baked for at least 30 to 120 minutes at 60°C. before putting into xylene for de-paraffinization. Baked slides were sent out baked for 2 hours.
In the following specsheet,“*” means invalid core; “-” means no applicable or negative in IHC markers."

  • 说明书列表
  • 重复病例
  • 下载说明书
图表:
Lung
  • Malignant(IA)
  • Malignant(IB)
  • Malignant(IIA)
  • Malignant(IIB)
  • Malignant(IIIA)
  • Malignant(IIIB)
  • Malignant(IV)
  • NAT(*)
组织芯片
RLN1261a
1
2
3
4
5
6
7
8
9
10
11
12
A
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
B
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
C
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
D
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
E
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
F
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
G
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
H
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
I
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
J
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
Lun
K
Lun
Lun
Lun
Lun
Lun
Lun
RLN1261a
  • 年龄:
  • 性别:
  • 器官/解剖部位:
  • 病理诊断:
  • 等级:
  • 分期:
  • 阶段:
  • 组织ID.:
  • 类型:
位置 No. Age Sex Organ/Anatomic Site Pathology diagnosis Grade TNM Stage Type Tumor size
A1
1 58 F Lung Acinar adenocarcinoma 2 T2bN1M0 IIB Malignant 6.5*5.0*4.5
A2
2 58 F Lung Acinar adenocarcinoma 2 T2bN1M0 IIB Malignant 6.5*5.0*4.5
A3
3 62 M Lung Adenocarcinoma 2 T2aN0M0 IB Malignant 4.5*4.0*3.0
A4
4 62 M Lung Adenocarcinoma 2 T2aN0M0 IB Malignant 4.5*4.0*3.0
A5
5 54 M Lung Adenocarcinoma (adherent growth predominant) 2 T2bN2M0 IIIA Malignant 4.0*4.0*2.5
A6
6 54 M Lung Adenocarcinoma (adherent growth predominant) 2 T2bN2M0 IIIA Malignant 4.0*4.0*2.5
A7
7 65 F Lung Adenocarcinoma 2 T2bN2M0 IIIA Malignant *
A8
8 65 F Lung Adenocarcinoma 2 T2bN2M0 IIIA Malignant *
A9
9 62 M Lung Adenocarcinoma 2 T2aN0M0 IB Malignant 4.0*3.5*3.0
A10
10 62 M Lung Adenocarcinoma 2 T2aN0M0 IB Malignant 4.0*3.5*3.0
A11
11 65 M Lung Adenocarcinoma 2 T2bN0M0 IIA Malignant *
A12
12 65 M Lung Adenocarcinoma 2 T2bN0M0 IIA Malignant *
B1
13 48 M Lung Adenocarcinoma 2 T2N1M0 IIB Malignant *
B2
14 48 M Lung Adenocarcinoma 2 T2N1M0 IIB Malignant *
B3
15 57 M Lung Adenocarcinoma (lepidic predominant) 2 T2bN0M0 IIA Malignant 5.0*4.5*4.5
B4
16 57 M Lung Adenocarcinoma (lepidic predominant) 2 T2bN0M0 IIA Malignant 5.0*4.5*4.5
B5
17 67 M Lung Invasive adenocarcinoma 2 T2aN0M0 IB Malignant 4.0*2.5*2.0
B6
18 67 M Lung Invasive adenocarcinoma 2 T2aN0M0 IB Malignant 4.0*2.5*2.0
B7
19 58 F Lung Papillary adenocarcinoma 2 T2aN0M0 IB Malignant 4*3*1.5
B8
20 58 F Lung Papillary adenocarcinoma 2 T2aN0M0 IB Malignant 4*3*1.5
B9
21 49 M Lung Adenocarcinoma 2 T2N0M0 IB Malignant 5
B10
22 49 M Lung Adenocarcinoma 2 T2N0M0 IB Malignant 5
B11
23 39 F Lung Adenocarcinoma 2--3 T2aN0M0 IB Malignant *
B12
24 39 F Lung Adenocarcinoma 2--3 T2aN0M0 IB Malignant *
C1
25 71 F Lung Adenocarcinoma 2--3 T2N1M0 IIB Malignant *
C2
26 71 F Lung Adenocarcinoma 2--3 T2N1M0 IIB Malignant *
C3
27 53 M Lung Adenocarcinoma 3 T2N0M0 IB Malignant 9.5*7*6
C4
28 53 M Lung Adenocarcinoma 3 T2N0M0 IB Malignant 9.5*7*6
C5
29 65 M Lung Adenocarcinoma 3 T2aN2M0 IIIA Malignant 5.0*5.0*3.5
C6
30 65 M Lung Adenocarcinoma 3 T2aN2M0 IIIA Malignant 5.0*5.0*3.5
C7
31 40 M Lung Adenocarcinoma 3 T2N0M0 IB Malignant 6
C8
32 40 M Lung Adenocarcinoma 3 T2N0M0 IB Malignant 6
C9
33 64 F Lung Adenocarcinoma 3 T2N0M0 IB Malignant *
C10
34 64 F Lung Adenocarcinoma 3 T2N0M0 IB Malignant *
C11
35 68 M Lung Solid adenocarcinoma 3 T2N1M1 IV Malignant *
C12
36 68 M Lung Solid adenocarcinoma 3 T2N1M1 IV Malignant *
D1
37 58 M Lung Adenocarcinoma 3 T2N0M0 IB Malignant 6.5*4.5*3.5
D2
38 58 M Lung Adenocarcinoma 3 T2N0M0 IB Malignant 6.5*4.5*3.5
D3
39 58 F Lung Adenocarcinoma 3 T2aN0M0 IB Malignant *
D4
40 58 F Lung Adenocarcinoma 3 T2aN0M0 IB Malignant *
D5
41 56 F Lung Invasive mucinous adenocarcinoma 3 T2aN1M0 IIB Malignant 7*7*3.5
D6
42 56 F Lung Invasive mucinous adenocarcinoma 3 T2aN1M0 IIB Malignant 7*7*3.5
D7
43 62 M Lung Adenocarcinoma 3 T2aN0M0 IB Malignant *
D8
44 62 M Lung Adenocarcinoma 3 T2aN0M0 IB Malignant *
D9
45 48 F Lung Adenocarcinoma 3 T2AN0M0 IB Malignant 5*4.0*3
D10
46 48 F Lung Adenocarcinoma 3 T2AN0M0 IB Malignant 5*4.0*3
D11
47 48 M Lung Adenocarcinoma 3 T3N1M0 IIIA Malignant 4
D12
48 48 M Lung Adenocarcinoma 3 T3N1M0 IIIA Malignant 4
E1
49 56 F Lung Adenocarcinoma 3 T2aN1M0 IIB Malignant 7*5*3.5
E2
50 56 F Lung Adenocarcinoma 3 T2aN1M0 IIB Malignant 7*5*3.5
E3
51 43 M Lung Adenocarcinoma 3 T2aN0M0 IB Malignant 5.0*3.0*2.5
E4
52 43 M Lung Adenocarcinoma 3 T2aN0M0 IB Malignant 5.0*3.0*2.5
E5
53 69 M Lung Solid adenocarcinoma 3 T3N1M0 IIIA Malignant *
E6
54 69 M Lung Solid adenocarcinoma 3 T3N1M0 IIIA Malignant *
E7
55 40 M Lung Adenocarcinoma 3 T2N0M0 IB Malignant 4.5
E8
56 40 M Lung Adenocarcinoma 3 T2N0M0 IB Malignant 4.5
E9
57 70 M Lung Adenocarcinoma 3 T3N1M0 IIIA Malignant 7
E10
58 70 M Lung Adenocarcinoma 3 T3N1M0 IIIA Malignant 7
E11
59 65 M Lung Adenocarcinoma 3 T2N1M0 IIB Malignant 5*4*3.5
E12
60 65 M Lung Adenocarcinoma 3 T2N1M0 IIB Malignant 5*4*3.5
F1
61 48 M Lung Adenocarcinoma 3 T2N0M0 IB Malignant 6
F2
62 48 M Lung Adenocarcinoma 3 T2N0M0 IB Malignant 6
F3
63 67 M Lung Adenocarcinoma 3 T2aN0M0 IB Malignant 3*2
F4
64 67 M Lung Adenocarcinoma 3 T2aN0M0 IB Malignant 3*2
F5
65 65 F Lung Adenocarcinoma 3 T3N1M0 IIIA Malignant *
F6
66 65 F Lung Adenocarcinoma 3 T3N1M0 IIIA Malignant *
F7
67 72 M Lung Papillary adenocarcinoma 3 T3N0M0 IIB Malignant 6
F8
68 72 M Lung Papillary adenocarcinoma 3 T3N0M0 IIB Malignant 6
F9
69 67 M Lung Adenosquamous carcinoma * T2aN0M0 IB Malignant *
F10
70 67 M Lung Adenosquamous carcinoma * T2aN0M0 IB Malignant *
F11
71 64 M Lung Adenosquamous carcinoma * T2aN0M0 IB Malignant *
F12
72 64 M Lung Adenosquamous carcinoma * T2aN0M0 IB Malignant *
G1
73 48 M Lung Squamous cell carcinoma 1 T2N1M0 IIB Malignant *
G2
74 48 M Lung Squamous cell carcinoma 1 T2N1M0 IIB Malignant *
G3
75 53 M Lung Squamous cell carcinoma 1 T2N0M0 IB Malignant 3*3*3
G4
76 53 M Lung Squamous cell carcinoma 1 T2N0M0 IB Malignant 3*3*3
G5
77 60 M Lung Squamous cell carcinoma 1 T2N1M0 IIB Malignant 4*3*3
G6
78 60 M Lung Squamous cell carcinoma 1 T2N1M0 IIB Malignant 4*3*3
G7
79 30 M Lung Squamous cell carcinoma 1--2 T2N0M0 IB Malignant *
G8
80 30 M Lung Squamous cell carcinoma 1--2 T2N0M0 IB Malignant *
G9
81 50 M Lung Squamous cell carcinoma 1--2 T2N0M0 IB Malignant 7.5*5*4
G10
82 50 M Lung Squamous cell carcinoma 1--2 T2N0M0 IB Malignant 7.5*5*4
G11
83 51 M Lung Squamous cell carcinoma 1--2 T3N1M0 IIIA Malignant 6*5*5
G12
84 51 M Lung Squamous cell carcinoma 1--2 T3N1M0 IIIA Malignant 6*5*5
H1
85 65 M Lung Squamous cell carcinoma 2 T2aN0M0 IB Malignant *
H2
86 65 M Lung Squamous cell carcinoma 2 T2aN0M0 IB Malignant *
H3
87 72 M Lung Squamous cell carcinoma 2 T2N1M0 IIB Malignant 7*3*1.5
H4
88 72 M Lung Squamous cell carcinoma 2 T2N1M0 IIB Malignant 7*3*1.5
H5
89 46 M Lung Squamous cell carcinoma 2 T3N1M0 IIIA Malignant *
H6
90 46 M Lung Squamous cell carcinoma 2 T3N1M0 IIIA Malignant *
H7
91 69 M Lung Squamous cell carcinoma 2 T2N0M0 IB Malignant *
H8
92 69 M Lung Squamous cell carcinoma 2 T2N0M0 IB Malignant *
H9
93 63 M Lung Squamous cell carcinoma 2 T2bN0M0 IIA Malignant *
H10
94 63 M Lung Squamous cell carcinoma 2 T2bN0M0 IIA Malignant *
H11
95 58 M Lung Squamous cell carcinoma 2 T3N1M0 IIIA Malignant 4*4*3
H12
96 58 M Lung Squamous cell carcinoma 2 T3N1M0 IIIA Malignant 4*4*3
I1
97 69 M Lung Squamous cell carcinoma 2 T2N0M0 IB Malignant *
I2
98 69 M Lung Squamous cell carcinoma 2 T2N0M0 IB Malignant *
I3
99 69 M Lung Squamous cell carcinoma 2 T2N1M0 IIB Malignant 7*5*4
I4
100 69 M Lung Squamous cell carcinoma 2 T2N1M0 IIB Malignant 7*5*4
I5
101 67 M Lung Squamous cell carcinoma 2--3 T2N0M0 IB Malignant 3*2.5
I6
102 67 M Lung Squamous cell carcinoma 2--3 T2N0M0 IB Malignant 3*2.5
I7
103 45 M Lung Squamous cell carcinoma 2--3 T2N0M0 IB Malignant 4*3*1
I8
104 45 M Lung Squamous cell carcinoma 2--3 T2N0M0 IB Malignant 4*3*1
I9
105 67 M Lung Squamous cell carcinoma 3 T2bN1M0 IIB Malignant 7*6*6
I10
106 67 M Lung Squamous cell carcinoma 3 T2bN1M0 IIB Malignant 7*6*6
I11
107 68 M Lung Squamous cell carcinoma 3 T4N1M0 IIIA Malignant 8*7*5
I12
108 68 M Lung Squamous cell carcinoma 3 T4N1M0 IIIA Malignant 8*7*5
J1
109 54 M Lung Squamous cell carcinoma 3 T1N0M0 IA Malignant 1.5*1.3*1.2
J2
110 54 M Lung Squamous cell carcinoma 3 T1N0M0 IA Malignant 1.5*1.3*1.2
J3
111 45 F Lung Squamous cell carcinoma 3 T2N0M0 IB Malignant 5*4*2.5
J4
112 45 F Lung Squamous cell carcinoma 3 T2N0M0 IB Malignant 5*4*2.5
J5
113 30 M Lung Squamous cell carcinoma 3 T2aN0M0 IB Malignant 4.5*4*3
J6
114 30 M Lung Squamous cell carcinoma 3 T2aN0M0 IB Malignant 4.5*4*3
J7
115 56 M Lung Squamous cell carcinoma 3 T3N2M0 IIIB Malignant 7*6*5
J8
116 56 M Lung Squamous cell carcinoma 3 T3N2M0 IIIB Malignant 7*6*5
J9
117 35 M Lung Squamous cell carcinoma 3 T1bN0M0 IA Malignant 3*3*2
J10
118 35 M Lung Squamous cell carcinoma 3 T1bN0M0 IA Malignant 3*3*2
J11
119 70 M Lung Squamous cell carcinoma 3 T2aN0M0 IB Malignant *
J12
120 70 M Lung Squamous cell carcinoma 3 T2aN0M0 IB Malignant *
K1
121 41 M Lung Squamous cell carcinoma 3 T2N0M0 IB Malignant 4*3*2
K2
122 41 M Lung Squamous cell carcinoma 3 T2N0M0 IB Malignant 4*3*2
K3
123 54 M Lung Adjacent normal lung tissue * * * NAT *
K4
124 54 M Lung Adjacent normal lung tissue * * * NAT *
K5
125 62 M Lung Adjacent normal lung tissue * * * NAT *
K6
126 62 M Lung Adjacent normal lung tissue * * * NAT *
查找与该芯片存在重复病例的芯片:
如需了解产品规格方面的任何问题,请联系我们:support@arraysbank.com
0.084678s